Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a clinical trial at HonorHealth Research ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

a type of cancer that develops in the squamous cells of the skin. But there are other ways to treat the cancer if a CSCC is very superficial (meaning it hasn’t penetrated below the top layer of ...

The most common are basal cell and squamous cell skin cancers, and if caught early, can be treated in a dermatologist’s office. More serious types, like melanoma require a surgical oncologist.

There are several different types of skin cancer, and some are more serious than others. The two most common are basal and squamous cell carcinomas. These skin cancers originate in the basal and ...